Skip to main content
Erschienen in: Der Nervenarzt 1/2013

01.01.2013 | Übersichten

Hormonersatztherapie und deren Wirkung auf Psyche und Gehirn

verfasst von: P. Baldinger, G. Kranz, A. Höflich, M. Savli, P. Stein, R. Lanzenberger, Prof. Dr. Dr. h.c. mult. S. Kasper

Erschienen in: Der Nervenarzt | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Zusammenfassung

Während der Perimenopause führen hormonelle Schwankungen neben körperlichen Beschwerden auch zu einem gehäuften Auftreten psychischer Symptome wie Stimmungslabilität, depressiven Episoden, Panikattacken und Schlafstörungen. Gerade bei Depressionen und Angst ist die bedeutsame Rolle des Neurotransmitters Serotonin in der Krankheitsentstehung unbestritten, aber nur wenig ist über den Einfluss der Sexualhormone auf das Serotoninsystem bekannt. Dieser Beitrag soll eine Übersicht über die Risikofaktoren für eine depressive Erkrankung im menopausalen Übergang bieten und mögliche Therapieansätze diskutieren: Aktuelle Forschungsergebnisse aus longitudinalen Studien zur Wirksamkeit der Hormonersatztherapie und serotonerg wirkender Antidepressiva in der Behandlung von körperlichen und psychischen Beschwerden in der Perimenopause werden präsentiert. Darüber hinaus werden Studien vorgestellt, die mittels Positronenemissionstomographie und genetischer Methoden versuchen, Effekte der Sexualhormone auf einzelne Komponenten des Serotoninsystems zu erforschen. Die Wechselwirkungen zwischen Östrogen, Progesteron und dem serotonergen System werden beschrieben und die möglichen neurobiologischen und endokrinen Ursachen depressiver Symptome in der Perimenopause beleuchtet.
Literatur
1.
Zurück zum Zitat Bethea CL, Lu NZ, Gundlah C et al (2002) Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23:41–100PubMedCrossRef Bethea CL, Lu NZ, Gundlah C et al (2002) Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23:41–100PubMedCrossRef
2.
Zurück zum Zitat Eurostat epp.eurostat.ec.europa.eu/portal/page/portal/statistics/search_database. In Eurostat epp.eurostat.ec.europa.eu/portal/page/portal/statistics/search_database. In
3.
Zurück zum Zitat Feld J, Halbreich U, Karkun S (2005) The association of perimenopausal mood disorders with other reproductive-related disorders. CNS Spectr 10:461–470PubMed Feld J, Halbreich U, Karkun S (2005) The association of perimenopausal mood disorders with other reproductive-related disorders. CNS Spectr 10:461–470PubMed
4.
Zurück zum Zitat Girdler SS, Straneva PA, Light KC et al (2001) Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 49:788–797PubMedCrossRef Girdler SS, Straneva PA, Light KC et al (2001) Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 49:788–797PubMedCrossRef
5.
Zurück zum Zitat Hildebrandt T, Alfano L, Tricamo M et al (2010) Conceptualizing the role of estrogens and serotonin in the development and maintenance of bulimia nervosa. Clin Psychol Rev 30:655–668PubMedCrossRef Hildebrandt T, Alfano L, Tricamo M et al (2010) Conceptualizing the role of estrogens and serotonin in the development and maintenance of bulimia nervosa. Clin Psychol Rev 30:655–668PubMedCrossRef
6.
Zurück zum Zitat Jans LA, Riedel WJ, Markus CR et al (2007) Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry 12:522–543PubMedCrossRef Jans LA, Riedel WJ, Markus CR et al (2007) Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry 12:522–543PubMedCrossRef
7.
Zurück zum Zitat Jarkova NB, Martenyi F, Masanauskaite D et al (2002) Mood effect of raloxifene in postmenopausal women. Maturitas 42:71–75PubMedCrossRef Jarkova NB, Martenyi F, Masanauskaite D et al (2002) Mood effect of raloxifene in postmenopausal women. Maturitas 42:71–75PubMedCrossRef
8.
Zurück zum Zitat Lanzenberger R, Mitterhauser M, Kranz GS et al (2012) Progesterone level predicts serotonin-1A receptor binding in the male human brain. Neuroendocrinology (in press) Lanzenberger R, Mitterhauser M, Kranz GS et al (2012) Progesterone level predicts serotonin-1A receptor binding in the male human brain. Neuroendocrinology (in press)
9.
Zurück zum Zitat Lemonde S, Turecki G, Bakish D et al (2003) Impaired repression at a 5hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23:8788–8799PubMed Lemonde S, Turecki G, Bakish D et al (2003) Impaired repression at a 5hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23:8788–8799PubMed
10.
Zurück zum Zitat Mize AL, Poisner AM, Alper RH (2001) Estrogens act in rat hippocampus and frontal cortex to produce rapid, receptor-mediated decreases in serotonin 5-HT(1A) receptor function. Neuroendocrinology 73:166–174PubMedCrossRef Mize AL, Poisner AM, Alper RH (2001) Estrogens act in rat hippocampus and frontal cortex to produce rapid, receptor-mediated decreases in serotonin 5-HT(1A) receptor function. Neuroendocrinology 73:166–174PubMedCrossRef
11.
Zurück zum Zitat Morrison MF, Kallan MJ, Ten Have T et al (2004) Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 55:406–412PubMedCrossRef Morrison MF, Kallan MJ, Ten Have T et al (2004) Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 55:406–412PubMedCrossRef
12.
Zurück zum Zitat Moses-Kolko EL, Wisner KL, Price JC et al (2008) Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study. Fertil Steril 89:685–692PubMedCrossRef Moses-Kolko EL, Wisner KL, Price JC et al (2008) Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study. Fertil Steril 89:685–692PubMedCrossRef
13.
Zurück zum Zitat Moses EL, Drevets WC, Smith G et al (2000) Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol Psychiatry 48:854–860PubMedCrossRef Moses EL, Drevets WC, Smith G et al (2000) Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol Psychiatry 48:854–860PubMedCrossRef
14.
Zurück zum Zitat Mossner R, Mikova O, Koutsilieri E et al (2007) Consensus paper of the WFSBP task force on biological markers: biological markers in depression. World J Biol Psychiatry 8:141–174PubMedCrossRef Mossner R, Mikova O, Koutsilieri E et al (2007) Consensus paper of the WFSBP task force on biological markers: biological markers in depression. World J Biol Psychiatry 8:141–174PubMedCrossRef
16.
Zurück zum Zitat Neumeister A, Konstantinidis A, Stastny J et al (2002) Association between serotonin transporter gene promoter polymorphism (5httlpr) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 59:613–620PubMedCrossRef Neumeister A, Konstantinidis A, Stastny J et al (2002) Association between serotonin transporter gene promoter polymorphism (5httlpr) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 59:613–620PubMedCrossRef
18.
Zurück zum Zitat Pearlstein T, Howard M, Salisbury A et al (2009) Postpartum depression. Am J Obstet Gynecol 200:357–364PubMedCrossRef Pearlstein T, Howard M, Salisbury A et al (2009) Postpartum depression. Am J Obstet Gynecol 200:357–364PubMedCrossRef
19.
Zurück zum Zitat Pecins-Thompson M, Brown NA, Bethea CL (1998) Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res Mol Brain Res 53:120–129PubMedCrossRef Pecins-Thompson M, Brown NA, Bethea CL (1998) Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res Mol Brain Res 53:120–129PubMedCrossRef
20.
Zurück zum Zitat Reddy DS (2010) Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res 186:113–137PubMedCrossRef Reddy DS (2010) Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res 186:113–137PubMedCrossRef
21.
Zurück zum Zitat Schmidt PJ, Rubinow DR (2009) Sex hormones and mood in the perimenopause. Ann N Y Acad Sci 1179:70–85PubMedCrossRef Schmidt PJ, Rubinow DR (2009) Sex hormones and mood in the perimenopause. Ann N Y Acad Sci 1179:70–85PubMedCrossRef
22.
Zurück zum Zitat Schneider LS, Small GW, Hamilton SH et al (1997) Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am J Geriatr Psychiatry 5:97–106PubMed Schneider LS, Small GW, Hamilton SH et al (1997) Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am J Geriatr Psychiatry 5:97–106PubMed
23.
Zurück zum Zitat Soares CN (2008) Depression during the menopausal transition: window of vulnerability or continuum of risk? Menopause 15:207–209PubMedCrossRef Soares CN (2008) Depression during the menopausal transition: window of vulnerability or continuum of risk? Menopause 15:207–209PubMedCrossRef
24.
Zurück zum Zitat Soares CN, Almeida OP, Joffe H et al (2001) Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebocontrolled trial. Arch Gen Psychiatry 58:529–534PubMedCrossRef Soares CN, Almeida OP, Joffe H et al (2001) Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebocontrolled trial. Arch Gen Psychiatry 58:529–534PubMedCrossRef
25.
Zurück zum Zitat Soares CN, Poitras JR, Prouty J (2003) Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause. Drugs Aging 20:85–100PubMedCrossRef Soares CN, Poitras JR, Prouty J (2003) Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause. Drugs Aging 20:85–100PubMedCrossRef
26.
Zurück zum Zitat Sumner BE, Fink G (1993) Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain. Mol Cell Neurosci 4:83–92PubMedCrossRef Sumner BE, Fink G (1993) Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain. Mol Cell Neurosci 4:83–92PubMedCrossRef
27.
Zurück zum Zitat Thompson DS, Spanier CA, Vogel VG (1999) The relationship between tamoxifen, estrogen, and depressive symptoms. Breast J 5:375–382PubMedCrossRef Thompson DS, Spanier CA, Vogel VG (1999) The relationship between tamoxifen, estrogen, and depressive symptoms. Breast J 5:375–382PubMedCrossRef
28.
Zurück zum Zitat Utian WH, Archer DF, Bachmann GA et al (2008) Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause 15:584–602PubMedCrossRef Utian WH, Archer DF, Bachmann GA et al (2008) Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause 15:584–602PubMedCrossRef
29.
Zurück zum Zitat Uzunova V, Sheline Y, Davis JM et al (1998) Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A 95:3239–3244PubMedCrossRef Uzunova V, Sheline Y, Davis JM et al (1998) Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A 95:3239–3244PubMedCrossRef
30.
Zurück zum Zitat Uzunova V, Wrynn AS, Kinnunen A et al (2004) Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat. Eur J Pharmacol 486:31–34PubMedCrossRef Uzunova V, Wrynn AS, Kinnunen A et al (2004) Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat. Eur J Pharmacol 486:31–34PubMedCrossRef
31.
Zurück zum Zitat Werner A, Johns G, Hoctor E et al (1934) Involutional melancholia: probable etiology and treatment. JAMA 103:13–16CrossRef Werner A, Johns G, Hoctor E et al (1934) Involutional melancholia: probable etiology and treatment. JAMA 103:13–16CrossRef
32.
Zurück zum Zitat Wise DD, Felker A, Stahl SM (2008) Tailoring treatment of depression for women across the reproductive lifecycle: the importance of pregnancy, vasomotor symptoms, and other estrogen-related events in psychopharmacology. CNS Spectr 13:647–662PubMed Wise DD, Felker A, Stahl SM (2008) Tailoring treatment of depression for women across the reproductive lifecycle: the importance of pregnancy, vasomotor symptoms, and other estrogen-related events in psychopharmacology. CNS Spectr 13:647–662PubMed
33.
Zurück zum Zitat Yaffe K, Ettinger B, Pressman A et al (1998) Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biol Psychiatry 43:694–700PubMedCrossRef Yaffe K, Ettinger B, Pressman A et al (1998) Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biol Psychiatry 43:694–700PubMedCrossRef
34.
Metadaten
Titel
Hormonersatztherapie und deren Wirkung auf Psyche und Gehirn
verfasst von
P. Baldinger
G. Kranz
A. Höflich
M. Savli
P. Stein
R. Lanzenberger
Prof. Dr. Dr. h.c. mult. S. Kasper
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
Der Nervenarzt / Ausgabe 1/2013
Print ISSN: 0028-2804
Elektronische ISSN: 1433-0407
DOI
https://doi.org/10.1007/s00115-011-3456-7

Weitere Artikel der Ausgabe 1/2013

Der Nervenarzt 1/2013 Zur Ausgabe

Mitteilungen der DGPPN

Mitteilungen der DGPPN 1/2013